Your browser doesn't support javascript.
loading
Does variation in either age at start of therapy or duration of therapy make chemoprevention with finasteride cost-effective?
Stewart, S B; Scales, C D; Moul, J W; Reed, S D.
Affiliation
  • Stewart SB; Division of Urology, Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA. suzanne.stewart@duke.edu
Prostate Cancer Prostatic Dis ; 15(4): 380-5, 2012 Dec.
Article in En | MEDLINE | ID: mdl-22777393
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Markov Chains / Age Factors / Cost-Benefit Analysis Type of study: Health_economic_evaluation / Prognostic_studies Aspects: Patient_preference Limits: Aged / Humans / Male / Middle aged Language: En Journal: Prostate Cancer Prostatic Dis Journal subject: ENDOCRINOLOGIA / NEOPLASIAS / UROLOGIA Year: 2012 Document type: Article Affiliation country: United States Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Markov Chains / Age Factors / Cost-Benefit Analysis Type of study: Health_economic_evaluation / Prognostic_studies Aspects: Patient_preference Limits: Aged / Humans / Male / Middle aged Language: En Journal: Prostate Cancer Prostatic Dis Journal subject: ENDOCRINOLOGIA / NEOPLASIAS / UROLOGIA Year: 2012 Document type: Article Affiliation country: United States Country of publication: United kingdom